Mitochondrial biogenesis induction as a treatment strategy was first proposed by Moraes group as their chemical or transgenic induction of PGC1alpha transcription coactivator in severe mitochondrial COX deficiency improved RC function and delayed death of the mice (Wenz et al, 2008). Here, PPARGC1A is linked to hyperinsulinemic hypoglycemia, familial, 4.